Nanomedicine Research Journal

Nanomedicine Research Journal

Optimizing Exosome Enrichment: A Comparative Study in Pediatric Acute Lymphoblastic Leukemia Patients

Document Type : Original Research Article

Authors
1 Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Iran
2 Yeditepe University, Department of Genetics and Bioengineering, Atasehir, 34755 Istanbul, Turkiye
Abstract
Objective(s): Pediatric acute lymphoblastic leukemia (pALL) is the most prevalent neoplasm in children. pALL diagnostic process is invasive, and children need to be anesthetized for bone marrow aspiration. Exosomes are nanoparticles that reflect the status of parental cells. Given the elevated levels of exosomes in the peripheral blood of pALL patients, they can be readily extracted from blood plasma. The aim of this study was to compare the reliability of two different techniques of exosome purification in order to select the best method for clinical use in pALL.
Methods: Exosomes were isolated from plasma samples using two methods: ultracentrifugation and the ExoQuick exosome isolation (EQ) kit. The performances of these methods were compared based on the nanoparticle tracking analysis (NTA), field emission electron microscopy (FESEM), and immunoblotting assays.
Results: NTA results showed that exosome fractions extracted by the EQ kit were more concentrated and homogeneous compared with the ultracentrifugation method. Electron microscopy depicted spherical morphology for the isolated exosomes in both methods; however, the appearance of exosomes enriched by the commercial kit was more intact. Following the immunoblotting assays investigating the exosomal biomarkers, densitometry analysis showed that the exosome populations related to the EQ kit had higher concentrations and extreme purity. 
Conclusions: The data demonstrated that the commercial kit exhibited superior efficacy in isolating concentrated, intact, and pure exosomes from small quantities of patients' plasma samples when compared to the standard ultracentrifugation method. According to those findings, the ExoQuick exosome segregation kit was preferred to be used in pALL diagnostic investigations. 
Keywords

Subjects


  1. Bartholomé R. Identification of circulation-derived exosomal microRNA candidates for liquid biopsy in pediatric acute lymphoblastic leukemia: lmu; 2022.
  2. Fu Y, Zhang Y, Khoo BLJMRR. Liquid biopsy technologies for hematological diseases. 2021;41(1):246-74. https://doi.org/10.1002/med.21731
  3. Kato M, Manabe AJPI. Treatment and biology of pediatric acute lymphoblastic leukemia. 2018;60(1):4-12. https://doi.org/10.1111/ped.13457
  4. Ukrainskaya V, Musatova O, Volkov D, Osipova D, Pershin D, Moysenovich A, et al. CAR-tropic extracellular vesicles carry tumor-associated antigens and modulate CAR T cell functionality. 2023;13(1):463. https://doi.org/10.1038/s41598-023-27604-5
  5. Zhu S, Xing C, Li R, Cheng Z, Deng M, Luo Y, et al. Proteomic profiling of plasma exosomes from patients with B-cell acute lymphoblastic leukemia. 2022;12(1):11975. https://doi.org/10.1038/s41598-022-16282-4
  6. Zhang Y, Ge T, Huang M, Qin Y, Liu T, Mu W, et al. Extracellular vesicles expressing CD19 Antigen improve expansion and efficacy of CD19-Targeted CAR-T cells. 2023:49-63. https://doi.org/10.2147/IJN.S390720
  7. Longjohn MN, Hudson J-AB, Peña-Castillo L, Cormier RP, Hannay B, Chacko S, et al. Extracellular vesicle small RNA cargo discriminates non-cancer donors from pediatric Bcell acute lymphoblastic leukemia patients. 2023;13:1272883. https://doi.org/10.3389/fonc.2023.1272883
  8. Miljkovic-Licina M, Arraud N, Zahra AD, Ropraz P, Matthes TJC. Quantification and phenotypic characterization of extracellular vesicles from patients with acute myeloid and B-cell lymphoblastic leukemia. 2021;14(1):56. https://doi.org/10.3390/cancers14010056
  9. Zhang J, Li S, Li L, Li M, Guo C, Yao J, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. 2015;13(1):17-24. https://doi.org/10.1016/j.gpb.2015.02.001
  10. Chai C, Sui K, Tang J, Yu H, Yang C, Zhang H, et al. BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution. 2023;13(12):3943. https://doi.org/10.7150/thno.83178
  11. Colangelo T, Panelli P, Mazzarelli F, Tamiro F, Melocchi V, De Santis E, et al. Extracellular vesicle microRNAs contribute to Notch signaling pathway in T-cell acute lymphoblastic leukemia. 2022;21(1):226. https://doi.org/10.1186/s12943-022-01698-3
  12. Bæk R, Søndergaard EK, Varming K, Jørgensen MMJJoIM. The impact of various preanalytical treatments on the phenotype of small extracellular vesicles in blood analyzed by protein microarray. 2016;438:11-20. https://doi.org/10.1016/j.jim.2016.08.007
  13. Salvianti F, Gelmini S, Costanza F, Mancini I, Sonnati G, Simi L, et al. The pre-analytical phase of the liquid biopsy. 2020;55:19-29. https://doi.org/10.1016/j.nbt.2019.09.006
  14. Lötvall J, Hill AF, Hochberg F, Buzás EI, Di Vizio D, Gardiner C, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. Taylor & Francis; 2014. p. 26913. https://doi.org/10.3402/jev.v3.26913
  15. Neerukonda SN, Egan NA, Patria J, Assakhi I, Tavlarides-Hontz P, Modla S, et al. Comparison of exosomes purified via ultracentrifugation (UC) and Total Exosome Isolation (TEI) reagent from the serum of Marek's disease virus (MDV)-vaccinated and tumor-bearing chickens. 2019;263:1-9. https://doi.org/10.1016/j.jviromet.2018.10.004
  16. Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. 2013;2(1):20360. https://doi.org/10.3402/jev.v2i0.20360
  17. Krafft C, Wilhelm K, Eremin A, Nestel S, von Bubnoff N, Schultze-Seemann W, et al. A specific spectral signature of serum and plasma-derived extracellular vesicles for cancer screening. 2017;13(3):835-41. https://doi.org/10.1016/j.nano.2016.11.016
  18. Théry C, Amigorena S, Raposo G, Clayton AJCpicb. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. 2006;30(1):3.22. 1-3.. 9. https://doi.org/10.1002/0471143030.cb0322s30
  19. Filipe V, Hawe A, Jiskoot WJPr. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. 2010;27:796-810. https://doi.org/10.1007/s11095-010-0073-2
  20. Azonano W. Reviewing the use of nanoparticle tracking analysis (NTA) for nanomaterial characterization. 2015.
  21. Andreu Z, Yáñez-Mó MJFii. Tetraspanins in extracellular vesicle formation and function. 2014;5:109543. https://doi.org/10.3389/fimmu.2014.00442
  22. McAndrews KM, Kalluri RJMc. Mechanisms associated with biogenesis of exosomes in cancer. 2019;18(1):52. https://doi.org/10.1186/s12943-019-0963-9
  23. Soares Martins T, Catita J, Martins Rosa I, AB da Cruz e Silva O, Henriques AGJPo. Exosome isolation from distinct biofluids using precipitation and column-based approaches. 2018;13(6):e0198820. https://doi.org/10.1371/journal.pone.0198820
  24. Yuana Y, Böing AN, Grootemaat AE, van der Pol E, Hau CM, Cizmar P, et al. Handling and storage of human body fluids for analysis of extracellular vesicles. 2015;4(1):29260. https://doi.org/10.3402/jev.v4.29260
  25. Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, et al. Impact of pre‐analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. 2012;10(3):437-46. https://doi.org/10.1111/j.1538-7836.2011.04610.x
  26. Yu L-L, Zhu J, Liu J-X, Jiang F, Ni W-K, Qu L-S, et al. A comparison of traditional and novel methods for the separation of exosomes from human samples. 2018;2018. https://doi.org/10.1155/2018/3634563
  27. Alvarez ML, Khosroheidari M, Ravi RK, DiStefano JKJKi. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. 2012;82(9):1024-32. https://doi.org/10.1038/ki.2012.256
  28. Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PPJBri. Isolation of extracellular vesicles: general methodologies and latest trends. 2018;2018. https://doi.org/10.1155/2018/8545347
  29. Yang D, Zhang W, Zhang H, Zhang F, Chen L, Ma L, et al. Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics. 2020;10(8):3684. https://doi.org/10.7150/thno.41580
  30. Sidhom K, Obi PO, Saleem AJIJoMS. A review of exosomal isolation methods: is size exclusion chromatography the best option? 2020;21(18):6466. https://doi.org/10.3390/ijms21186466
  31. Palviainen M, Saraswat M, Varga Z, Kitka D, Neuvonen M, Puhka M, et al. Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo-Implications for biomarker discovery. 2020;15(8):e0236439. https://doi.org/10.1371/journal.pone.0236439
  32. Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. 2018;7(1):1535750. https://doi.org/10.1080/20013078.2018.1461450
  33. Nazarenko IJTLB. Extracellular vesicles: Recent developments in technology and perspectives for cancer liquid biopsy. 2020:319-44. https://doi.org/10.1007/978-3-030-26439-0_17
  34. Lobb RJ, Becker M, Wen Wen S, Wong CS, Wiegmans AP, Leimgruber A, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. 2015;4(1):27031. https://doi.org/10.3402/jev.v4.27031
  35. Coughlan C, Bruce KD, Burgy O, Boyd TD, Michel CR, Garcia‐Perez JE, et al. Exosome isolation by ultracentrifugation and precipitation and techniques for downstream analyses. 2020;88(1):e110. https://doi.org/10.1002/cpcb.110